Telomere dysfunction, oxidative damage and breast cancer risk

端粒功能障碍、氧化损伤和乳腺癌风险

基本信息

  • 批准号:
    7291553
  • 负责人:
  • 金额:
    $ 8.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-27 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Telomeres are specialized DNA-protein structures at the ends of linear chromosomes, and are essential for maintaining the integrity and stability of the genome. Telomere dysfunction can lead to genomic instability that in turn drives the tumorigenic process in pre-malignant breast lesions and normal breast tissues. Several genetic or environmental factors may affect telomere dysfunction, and modify breast cancer risk: (1) progressive loss of telomere repeat sequences due to the problem of replicating chromosome ends; (2) oxidative damage to telomeric DNA accelerating telomere shortening; (3) disruption of higher-order telomere structures due to defects in various telomere-binding proteins; (4) age, cigarette smoking, chronic inflammation and epigenetic modifications, etc. But there is little evidence from population studies. The broad and long-term objectives of the study are to clarify the etiological role of telomere dysfunction in breast cancer risk and the potential determinants for shortened telomeres. The specific aims of the present study are to: (1) Explore the association between telomere dysfunction and breast cancer risk in a large population-based case-control study - the Long Island Breast Cancer Study Project (LIBCSP). (2) Evaluate the modifying effects of oxidative damage (urinary 15-F2t-lsoP and 8-oxodG levels as biomarkers) and antioxidant capacity (antioxidants intake levels obtained from FFQ) on telomere dysfunction for breast cancer risk. (3) Screen for SNPs in key telomere stability genes that potential affect telomere function. Associations between 96 SNPs and shortening telomere, breast cancer risk will be determined. Quantitative PCR (Q-PCR) will be used to measure telomere length in peripheral blood lymphocytes (PBLs) among 800 cases and 800 controls as a biomarker of telomere dysfunction; Urinary 15-F2t-lsoP levels will be analyzed using immunoassay kits. Urinary 8-oxodG levels will be analyzed by competitive ELISA. The high through-put SNPIexTM genotyping system will be used to genotyped potential functional SNPs in key telomere stability genes. Understanding the role of telomere dysfunction in breast cancer risk and the modifying effect of oxidative damage and antioxidant capacity has important implications for improved preventive, diagnostic and treatment strategies for breast cancer.
描述(由申请人提供):端粒是位于线性染色体末端的专门的DNA-蛋白质结构,对于维持基因组的完整性和稳定性至关重要。端粒功能障碍可导致基因组不稳定性,进而驱动癌前乳腺病变和正常乳腺组织中的肿瘤发生过程。一些遗传或环境因素可能会影响端粒功能障碍,并改变乳腺癌的风险:(1)由于染色体末端复制问题导致端粒重复序列的进行性丢失;(2)端粒DNA的氧化损伤加速端粒缩短;(3)由于各种端粒结合蛋白的缺陷导致端粒高级结构的破坏;(4)年龄、吸烟、慢性炎症和表观遗传修饰等。这项研究的广泛和长期目标是阐明端粒功能障碍在乳腺癌风险中的病因作用以及端粒缩短的潜在决定因素。本研究的具体目的是:(1)在一项大型基于人群的病例对照研究-长岛乳腺癌研究计划(LIBCSP)中探索端粒功能障碍与乳腺癌风险之间的关系。(2)评估氧化损伤(尿15-F2 t-lsoP和8-oxodG水平作为生物标志物)和抗氧化能力(从FFQ获得的抗氧化剂摄入水平)对乳腺癌风险的端粒功能障碍的修饰作用。(3)筛选可能影响端粒功能的关键端粒稳定性基因中的SNP。将确定96个SNP与端粒缩短和乳腺癌风险之间的关联。将使用定量PCR(Q-PCR)测量800例病例和800例对照的外周血淋巴细胞(PBL)中的端粒长度,作为端粒功能障碍的生物标志物;将使用免疫测定试剂盒分析尿15-F2 t-lsoP水平。将通过竞争性ELISA分析尿8-oxodG水平。高通量SNPIexTM基因分型系统将用于对关键端粒稳定性基因中的潜在功能SNP进行基因分型。了解端粒功能障碍在乳腺癌风险中的作用以及氧化损伤和抗氧化能力的修饰作用对改善乳腺癌的预防,诊断和治疗策略具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Shen其他文献

Jing Shen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Shen', 18)}}的其他基金

Identifying the perceptual factors that contribute to older listeners'''' dynamic pitch benefit for speech recognition in noise.
识别有助于老年听众动态音高的感知因素,有利于噪声中的语音识别。
  • 批准号:
    10307057
  • 财政年份:
    2019
  • 资助金额:
    $ 8.31万
  • 项目类别:
Identifying the perceptual factors that contribute to older listeners'''' dynamic pitch benefit for speech recognition in noise.
识别有助于老年听众动态音高的感知因素,有利于噪声中的语音识别。
  • 批准号:
    10247973
  • 财政年份:
    2019
  • 资助金额:
    $ 8.31万
  • 项目类别:
Ability of older adults to benefit from dynamic pitch for speech recognition in noise
老年人受益于噪声中语音识别的动态音调的能力
  • 批准号:
    8980477
  • 财政年份:
    2015
  • 资助金额:
    $ 8.31万
  • 项目类别:
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
肝细胞癌 (HCC) 中 MicroRNA 基因的异常 DNA 甲基化
  • 批准号:
    8330235
  • 财政年份:
    2011
  • 资助金额:
    $ 8.31万
  • 项目类别:
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
肝细胞癌 (HCC) 中 MicroRNA 基因的异常 DNA 甲基化
  • 批准号:
    8190296
  • 财政年份:
    2011
  • 资助金额:
    $ 8.31万
  • 项目类别:
Telomere dysfunction, oxidative damage and breast cancer risk
端粒功能障碍、氧化损伤和乳腺癌风险
  • 批准号:
    7213985
  • 财政年份:
    2006
  • 资助金额:
    $ 8.31万
  • 项目类别:

相似海外基金

6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10305569
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
  • 批准号:
    10488244
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10488242
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10488237
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
  • 批准号:
    10305565
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
  • 批准号:
    10305568
  • 财政年份:
    2021
  • 资助金额:
    $ 8.31万
  • 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
  • 批准号:
    1903855
  • 财政年份:
    2019
  • 资助金额:
    $ 8.31万
  • 项目类别:
    Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2017
  • 资助金额:
    $ 8.31万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2015
  • 资助金额:
    $ 8.31万
  • 项目类别:
    Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
  • 批准号:
    311600-2013
  • 财政年份:
    2014
  • 资助金额:
    $ 8.31万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了